Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 231
Selected: 0
NCT IDTitle
NCT07151872Combination of QLS31905 and Chemotherapy ± QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract Cancer
NCT06837896Efficacy and Safety Study of QLG1080 in Patients With Hormone-sensitive Advanced Prostate Cancer
NCT05149924Efficacy and Safety of QL1012 in Women for Assisted Reproductive Treatment
NCT05884801Phase I Study of QLS1103 in Subjects With Advanced Solid Tumors
NCT06936748SFRT+Sequential Hypofractionated/Conventional Fractionated RT+Iparomlimab and Tuvonralimab for Relapsed/Refractory Solid Tumors
NCT07327697A Comparative Phase 1 Study to Evaluate the Pharmacokinetic and Safety of QL2302 vs. Tezspire® in Healthy Subjects
NCT05179317Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy With or Without Bevacizumab in Women With Recurrent, or Metastatic Cervical Cancer
NCT05055687Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD/MAD)
NCT07178171A Study of QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC
NCT05851027Evaluating the Efficacy and Safety of QL0911 in Chemotherapy- Induced Thrombocytopenia
NCT06446388Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors
NCT06742138To Evaluate the Efficacy and Safety of QL2109 and DARZALEX FASPRO® in Multiple Myeloma
NCT06649214A Study of Olanzapine-Samidorphan Tablets in Adults With Schizophrenia
NCT05487391A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection.
NCT07272590Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid Tumors
NCT07313150A Phase I Trial of Subcutaneous QLS7305 in Healthy Adults
NCT03169335Efficacy and Safety of QL1101 and Avastin® Respectively Combined With Paclitaxel and Carboplatin in the First-line Treatment of Non-squamous Non-small Cell Lung Cancer
NCT07358884First in Human Study of QLS5316 in Solid Tumors
NCT06799559Study on the Efficacy and Safety of QLM1016 in Schizophrenia
NCT05689203A Phase 2 Study to Evaluate the Efficacy and Safety of QLS1128 Orally in Symptomatic Participants With Mild to Moderate COVID-19
NCT01946919Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study
NCT07327619A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABP
NCT07550465Study of QLS1410 in the Treatment of Primary Aldosteronism.
NCT07138209A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple Myeloma
NCT07400744A Study to Compare the PK , Safety, and Immunogenicity of QL2109 With Daratumumab in Male Subjects
NCT06456528QL0911 for the Treatment of Cancer Treatment-Induced Thrombocytopenia
NCT06058000A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis
NCT06007586Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients
NCT07025239QL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of Unresectable Metastatic Colorectal Cancer
NCT06911827A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients
NCT07444086QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia
NCT05802342A Multicenter, Randomized, Double-blind Phase II Trial to Evaluate GM1 Prevention of Peripheral Neuropathy in Patients With Breast Cancer
NCT06446310Phase 3 Study of QLG2198 in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus
NCT05531994Bioequivalence Study of Montelukast Sodium Oral Thin Film and Chewable Tablet in Fed Healthy Volunteers
NCT05058105Safety, Tolerability, Pharmacokinetics of Intravenous FL058 and Meropenem in Healthy Subjects(SAD/MAD)
NCT06232902A Study to Compare the Pharmacokinetics and Safety of QL1101 and EU-Avastin® in Healthy Volunteers
NCT02335879Phase III Clinical Study of Domestic Recombinant Human Follitropin for Injection to Treat WHO Class II Anovulation
NCT04641754A Study Evaluates the Safety and Efficacy of WX-0593 in ALK -Positive, or ROS1-positive Non-small Cell Lung Cancer
NCT07453394QLS5132 Combination Therapy in Advanced Solid Tumors
NCT04486430Efficacy and Safety Study of Neu2000KWL for Acute Ischemic Stroke Patients Within 6 Hours of Onset
NCT05108779QLF32004 Injection for the Treatment of Patients With Advanced Malignant Tumors
NCT06749899QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.
NCT04527068QL1101 in Combination With JS001 in Patients With pMMR/MSS Refractory Metastatic Colorectal Cancer
NCT06403735A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors
NCT03244085A Study to Investigate the Safety, Efficacy and Pharmacokinetic Profile of Multiple Doses of QL-007 in Chronic Hepatitis B Patients
NCT01931943A Phase Ib Study of Selatinib Ditosilate Tablets in Patients With Advanced Breast Cancer
NCT06822985QL1706 As Second-line Treatment in Patients with Advanced Hepatocellular Carcinoma
NCT05629949A Multicenter, Double-blind, Randomized, Parallel-group, Phase III Study of the Efficacy and Safety of QL1701 Plus Docetaxel Versus Herceptin® Plus Docetaxel as First Line Therapy in Patients With HER2-positive Metastatic Breast Cancer
NCT05543343Staphylococcus and Neisseria Tablets in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
NCT05278832A Study of QLS31905 in Patients With Advanced Solid Tumors